Archive for the 'Congress' Category

Senate Hearing Scheduled on Generic Drug Price Spikes

By Kevin Schweers

Senator Bernie Sanders (I-Vt.), Chairman of the Senate Subcommittee on Primary Health and Aging, announced that his panel will hold a hearing on Nov. 20 to “explore why the costs of certain generic drugs are skyrocketing.” NCPA appreciates the subcommittee’s work and will continue to support their efforts to address this issue.

Continue reading ‘Senate Hearing Scheduled on Generic Drug Price Spikes’

Patient-Centric Services on Display During Congressional Pharmacy Visits

By Michael Rule, Associate Director of Public Affairs and Grassroots Advocacy

Previously, The Dose posted a call to action during the August Congressional recess, imploring independent community pharmacists to use the opportunity to share their experiences with their elected officials, and encouraging them to host their elected officials for a pharmacy visit if possible. Over the course of the last several weeks, NCPA has received feedback from pharmacists demonstrating that several members of the House and Senate took advantage of the opportunity to tour a local pharmacy. The following are just a few examples visits that have taken place.

Continue reading ‘Patient-Centric Services on Display During Congressional Pharmacy Visits’

NCPA Ads Inform Congress on Community Pharmacists, Priorities

By Kevin Schweers

The more than 250 independent community pharmacists coming to Washington, DC this week for NCPA’s Legislative Conference will visit with hundreds of Members of Congress, but not all 535 Senators and Representatives. To reinforce with these lawmakers and others the value of community pharmacists and pharmacists’ federal policy priorities for 2013, NCPA is running advertisements in key publications.

Continue reading ‘NCPA Ads Inform Congress on Community Pharmacists, Priorities’

For 2013 Priorities, Pharmacist Engagement Essential for Success

By Michael Rule, Manager of Public Affairs and Grassroots Advocacy

In the days following President Obama’s second inaugural, NCPA ran ads calling on Congress and the White House to pass legislation important to independent community pharmacy. Specifically, NCPA asked Congress to pass legislation to enact common sense PBM reforms, protect patient pharmacy choice and patient access to traditional compounding pharmacies and to allow community pharmacies to provide certain healthcare services.

Continue reading ‘For 2013 Priorities, Pharmacist Engagement Essential for Success’

Get Active During Recess (Congress’ August Recess That Is)

By Michael Rule, Manager of Public Affairs and Grassroots Advocacy

As noted in a recent Executive Update (link available to NCPA members only) Congress has left Washington D.C. for its annual August Recess. During this period most Members of Congress will spend a significant portion of their time in district meeting with constituents. This presents a tremendous opportunity for pharmacists to meet with their legislators and educate them on the importance of small business independent community pharmacy to patients and the overall community. In fact, more than 25 members of Congress have already scheduled pharmacy visits for during this recess. Continue reading ‘Get Active During Recess (Congress’ August Recess That Is)’

NCPA, Coalition Back PDUFA Provisions to Address Drug Shortages

Alleviating drug shortages remains an important part of the prescription drug user fee bill before Congress, which is why NCPA and a number of other organizations representing clinicians, hospitals and patients sent a joint letter offering recommendations to Congressional leaders.

Continue reading ‘NCPA, Coalition Back PDUFA Provisions to Address Drug Shortages’

Congress Finalizing Drug User Fee Bill; NCPA Provides Pharmacist’s Perspective

Congress is actively working to reconcile Senate and House-passed versions of the Prescription Drug User Fee Act (PDUFA) and the National Community Pharmacists Association (NCPA) recently wrote to lawmakers to offer the pharmacist’s view.

Continue reading ‘Congress Finalizing Drug User Fee Bill; NCPA Provides Pharmacist’s Perspective’


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 507 other followers